3.3 IV Infusion Rates, Drop Factors, Osmolarity & Creatinine Clearance (Cockcroft-Gault)

3.3 IV Infusion Rates, Drop Factors, Osmolarity & Creatinine Clearance (Cockcroft-Gault)

Intravenous (IV) pharmacotherapy demands absolute quantitative precision. Unlike oral administration, where absorption barriers and first-pass hepatic metabolism provide a temporary buffer, intravenous infusions deliver active drugs and electrolytes directly into systemic circulation. Pharmacists must compute infusion pump flow rates, gravity drop factors, electrolyte combining powers in milliequivalents and millimoles, solution osmolarities, and renal dose titrations using the Cockcroft-Gault creatinine clearance formula.

---

Intravenous Infusion Dynamics: Volumetric Rates & Gravity Drop Factors

Intravenous solutions are administered either through electronic volumetric infusion pumps calibrated in millilitres per hour ($\text{mL/hr}$) or via gravity infusion sets regulated in drops per minute ($\text{gtt/min}$, from the Latin guttae):

Volumetric Pump Rate Calculations

$\text{Flow Rate (mL/hr)} = \frac{\text{Total Volume to Infuse (mL)}}{\text{Infusion Duration (hours)}}$

If an IV piggyback of piperacillin/tazobactam in $100\text{ mL}$ of normal saline is ordered over 30 minutes: $\text{Flow Rate} = \frac{100\text{ mL}}{0.5\text{ hours}} = 200\text{ mL/hr}$

Gravity Drip Sets and Drop Factors

When electronic infusion pumps are unavailable, the drip rate is manually timed by counting drops falling into the IV administration set drip chamber. Tubing manufacturers engineer drip orifices to deliver a calibrated number of drops per millilitre, known as the drop factor ($\text{gtt/mL}$):

$\text{Drip Rate (gtt/min)} = \frac{\text{Infusion Volume (mL)} \times \text{Drop Factor (gtt/mL)}}{\text{Infusion Duration (minutes)}}$

---

Electrolyte Posology: Milliequivalents, Millimoles, and Milligrams

Electrolyte concentrations are expressed in units of mass ($\text{mg}$ or $\text{g}$), molecular count ($\text{mmol}$), or chemical combining power ($\text{mEq}$):

• Mole / Millimole ($\text{mmol}$): Represents molecular quantity. One millimole equals the formula weight of the substance in milligrams: $\text{mmol} = \frac{\text{Weight (mg)}}{\text{Molecular Weight (g/mol)}}$
• Equivalent / Milliequivalent ($\text{mEq}$): Represents the chemical combining activity of an ion, factoring in its electrical charge (valence, $z$): $\text{mEq} = \frac{\text{Weight (mg)} \times \text{Valence}}{\text{Molecular Weight (g/mol)}} = \text{mmol} \times \text{Valence}$

For univalent ions ($\text{Na}^+, \text{K}^+, \text{Cl}^-, \text{HCO}_3^-$), $1\text{ mmol} = 1\text{ mEq}$. For divalent ions ($\text{Ca}^{2+}, \text{Mg}^{2+}$), $1\text{ mmol} = 2\text{ mEq}$.

Clinical Distinction: Calcium Chloride vs. Calcium Gluconate

In Canadian hospital practice, confusion between calcium salts carries fatal risks:

• Calcium Chloride Dihydrate ($\text{CaCl}_2 \cdot 2\text{H}_2\text{O}$, $\text{MW} = 147\text{ g/mol}$, valence = 2): $1\text{ g of } \text{CaCl}_2 = \frac{1,000\text{ mg} \times 2}{147} = 13.6\text{ mEq of } \text{Ca}^{2+} = 273\text{ mg of elemental Ca}$
• Calcium Gluconate ($\text{C}_{12}\text{H}_{22}\text{CaO}_{14}$, $\text{MW} = 430.4\text{ g/mol}$, valence = 2): $1\text{ g of calcium gluconate} = \frac{1,000\text{ mg} \times 2}{430.4} = 4.65\text{ mEq of } \text{Ca}^{2+} = 93\text{ mg of elemental Ca}$

Calcium chloride provides nearly three times more elemental calcium per gram than calcium gluconate. Furthermore, calcium chloride causes severe tissue sloughing and necrosis if extravasated and must be given centrally or in life-threatening cardiac arrest; calcium gluconate is the standard choice for peripheral replacement.

---

Parenteral Osmolarity, Tonicity & the Sodium Chloride Equivalent ($E$-Value)

Theoretical Osmolarity

Osmolarity expresses osmotic pressure as milliosmoles per litre of solution ($\text{mOsmol/L}$):

$\text{mOsmol/L} = \frac{\text{Weight of Solute (g/L)}}{\text{Molecular Weight (g/mol)}} \times \text{Number of Dissociated Particles} \times 1000$

• Normal human serum osmolarity ranges from $275\text{ to } 295\text{ mOsmol/kg}$.
• Normal Saline ($0.9\%\text{ w/v } \text{NaCl}$, $\text{MW} = 58.5$, dissociates into 2 ions: $\text{Na}^+$ and $\text{Cl}^-$): $\text{Osmolarity} = \frac{9\text{ g/L}}{58.5\text{ g/mol}} \times 2 \times 1000 = 307.7\text{ mOsmol/L} \approx 308\text{ mOsmol/L} \quad (\text{isotonic})$

Peripheral vs. Central Venous Access Threshold

Infusion of hypertonic solutions causes endothelial cell shrinkage, mechanical irritation, and chemical thrombophlebitis. In Canadian parenteral nutrition and intravenous standards, any peripheral IV solution must have an osmolarity $\le 900\text{ mOsmol/L}$. Formulations exceeding $900\text{ mOsmol/L}$ (e.g., concentrated total parenteral nutrition containing $>10\%$ dextrose or $>5\%$ amino acids) must be infused via a central venous line.

Tonicity Adjustment: The Sodium Chloride Equivalent ($E$-Value) Method

The $E$-value is the weight of sodium chloride that produces an identical osmotic effect to $1\text{ g}$ of the active medication. Pharmacists use a 3-step calculation to compound isotonic ophthalmic and parenteral solutions:

1. Calculate total NaCl required for isotonicity ($0.9\%\text{ w/v} = 0.009\text{ g/mL}$): $\text{Target NaCl (g)} = 0.009 \times \text{Batch Volume (mL)}$
2. Calculate the tonic contribution of the drug: $\text{Drug Contribution (g NaCl)} = \text{Weight of Drug (g)} \times E$
3. Calculate the required mass of NaCl to add: $\text{NaCl to Add (g)} = \text{Target NaCl (g)} - \text{Drug Contribution (g)}$

---

Renal Clearance Assessment: Cockcroft-Gault Posology in Canadian SI Units

While clinical biochemistry reports in Canada frequently provide estimated glomerular filtration rate (eGFR) via the CKD-EPI equation for disease classification, many product monographs base renal dose adjustments on Cockcroft-Gault creatinine clearance (CrCl), notably the direct oral anticoagulants (DOACs), many antimicrobials, and gabapentinoids. Other monographs and guidelines use eGFR instead (for example, SGLT2 inhibitor and metformin thresholds), so read which measure the label or the exam stem specifies.

The Cockcroft-Gault Equations

In Canadian hospital and ambulatory practice, serum creatinine ($S_{\text{cr}}$) is reported in SI units ($\mu\text{mol/L}$):

$\text{CrCl}_{\text{male}}\ (\text{mL/min}) = \frac{(140 - \text{Age}) \times \text{Weight (kg)} \times 1.2}{S_{\text{cr}}\ (\mu\text{mol/L})} \qquad \text{CrCl}_{\text{female}} = 0.85 \times \text{CrCl}_{\text{male}}$

When using conventional units ($S_{\text{cr}}$ in $\text{mg/dL}$):

$\text{CrCl (mL/min)} = \frac{(140 - \text{Age}) \times \text{Weight (kg)}}{72 \times S_{\text{cr}}\ (\text{mg/dL})} \times [0.85 \text{ if female}]$

Conversion Factor: $S_{\text{cr}}\ (\mu\text{mol/L}) = S_{\text{cr}}\ (\text{mg/dL}) \times 88.4$.

Weight Selection Rules in Cockcroft-Gault Calculations

In clinical practice, many hospital protocols pick the weight descriptor with the following algorithm. On the exam, follow the stem: use actual body weight by default, and use IBW or AdjBW only when the stem asks for it or gives you that value:

1. Calculate Ideal Body Weight (IBW) via Devine Formula: $\text{IBW}_{\text{male}} = 50\text{ kg} + 2.3 \times (\text{Height in inches} - 60)$ $\text{IBW}_{\text{female}} = 45.5\text{ kg} + 2.3 \times (\text{Height in inches} - 60)$

2. Apply the Weight Selection Algorithm:

   • Underweight (Actual Weight < IBW): Use Actual Body Weight (ABW). Using IBW would falsely overestimate clearance in cachectic or frail individuals.
   • Normal Weight (Actual Weight $100\%$ to $120\%$ of IBW): Use IBW. Adipose tissue contributes negligibly to creatinine generation.
   • Obese (Actual Weight > $120\%$ of IBW): Use Adjusted Body Weight (AdjBW): $\text{AdjBW} = \text{IBW} + 0.4 \times (\text{ABW} - \text{IBW})$

 Patient Weight Assessment:
 ├── Actual Weight < IBW                ──> Use Actual Body Weight (ABW)
 ├── Actual Weight = 100% to 120% IBW   ──> Use Ideal Body Weight (IBW)
 └── Actual Weight > 120% IBW (Obese)   ──> Use Adjusted Body Weight (AdjBW)

Worked Clinical Case: Renal Drug Dosing in Obesity

Case: A 70-year-old female patient (height: $165\text{ cm} = 65\text{ inches}$; actual weight: $92\text{ kg}$) is being evaluated for rivaroxaban therapy for non-valvular atrial fibrillation. Her laboratory panel shows $S_{\text{cr}} = 110\ \mu\text{mol/L}$.

1. Calculate IBW: $\text{IBW} = 45.5 + 2.3 \times (65 - 60) = 45.5 + 11.5 = 57.0\text{ kg}$

2. Evaluate Weight Ratio: $\frac{\text{ABW}}{\text{IBW}} = \frac{92\text{ kg}}{57\text{ kg}} = 1.61 = 161\% \quad (>120\% \implies \text{obese})$

3. Calculate Adjusted Body Weight: $\text{AdjBW} = 57.0 + 0.4 \times (92 - 57.0) = 57.0 + 0.4 \times (35.0) = 57.0 + 14.0 = 71.0\text{ kg}$

4. Calculate CrCl in SI Units: $\text{CrCl} = \frac{(140 - 70) \times 71.0\text{ kg} \times 1.2}{110\ \mu\text{mol/L}} \times 0.85 = \frac{5,964}{110} \times 0.85 \approx 46.1\text{ mL/min}$

5. Clinical Dose Implication: For rivaroxaban in non-valvular atrial fibrillation, Thrombosis Canada guidelines state: standard dose is $20\text{ mg}$ once daily if $\text{CrCl} \ge 50\text{ mL/min}$; reduce to $15\text{ mg}$ once daily if $\text{CrCl}$ is $30\text{--}49\text{ mL/min}$. Because her calculated $\text{CrCl}$ is about $46\text{ mL/min}$, she requires the adjusted dose of $15\text{ mg}$ once daily. With actual body weight ($92\text{ kg}$), the estimate would be about $60\text{ mL/min}$ and would point to the full dose, so the weight choice changes the decision here.